No Data
No Data
Henan Taloph Pharmaceutical Stock's performance pre-announcement for the first half of 2024.
Henan Taloph Pharmaceutical Stock (600222.SH) will distribute 0.018 yuan per share for the first quarter of 2024. The equity record date is July 8.
Henan Taloph Pharmaceutical Stock (600222.SH) released a notice on the implementation of equity distribution for the first quarter of 2024. The profit distribution for this time...
Henan Taloph Pharmaceutical Stock (600222.SH): Has repurchased 0.82% of its shares.
On July 2nd, Gelunhui reported that Henan Taloph Pharmaceutical Stock (600222.SH) has repurchased a total of 4,693,600 shares as of June 30, 2024, accounting for 0.82% of the total share capital. The highest repurchase price was 4.97 yuan per share, the lowest was 3.82 yuan per share, and the total amount paid was 21,274,189.00 yuan (excluding transaction fees).
Henan Taloph Pharmaceutical Stock (600222.SH): Cumulative expenditure of 15.275 million yuan to repurchase 0.59% of shares.
Henan Taloph Pharmaceutical Stock (600222.SH) announced on June 4 that as of May 31, 2024, the company has accumulated the repurchase of 3,358,700 shares, accounting for 0.59% of the total share capital of the company. The highest and lowest prices of the repurchase were 4.97 yuan/share and 3.82 yuan/share, respectively, and the total amount paid was 15,275,319.00 yuan (excluding transaction fees).
Tailong Pharmaceutical (600222.SH): A total of 0.31% of shares have been repurchased
Gelonghui, May 6, 丨 Tailong Pharmaceutical (600222.SH) announced that as of April 30, 2024, the company had repurchased 1,776,200 shares, accounting for 0.31% of the company's total share capital. The highest price of the repurchase transaction was 4.97 yuan/share, the lowest price was 3.82 yuan/share, and the total amount paid was 7,682,186.00 yuan (excluding transaction fees).
Tailong Pharmaceutical (600222.SH) announced first-quarter results, net profit of 21.26 million yuan, an increase of 477.28% year-on-year
Tailong Pharmaceutical (600222.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 4.9 during the reporting period...
No Data